Epidemiología del riesgo cardiovascular del hipertenso

2007 2003 European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension. Guidelines Committee. J Hypertens. 2003;21:1011-53. Marín, 2005, Guía sobre el diagnóstico y tratamiento de la hipertensión arterial en España 2005, Med Clin (Barc), 125, 24, 10.1157/13076402 Chobanian, 2003, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report, JAMA, 289, 2560, 10.1001/jama.289.19.2560 Kannel, 2002, Update on hypertension as a cardiovascular risk factor, 3 Goldstein, 2001, Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association, Circulation, 103, 163, 10.1161/01.CIR.103.1.163 2005, Hypertension in the twentieth century: concepts and achievements, 11 MacMahon, 1990, Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias, Lancet, 335, 765, 10.1016/0140-6736(90)90878-9 Vasan, 1996, The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview, Arch Intern Med, 156, 1789, 10.1001/archinte.1996.00440150033003 Benetos, 1998, Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects, Hypertension, 32, 560, 10.1161/01.HYP.32.3.560 Pastor, 2003, Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality, Ann Intern Med, 139, 731, 10.7326/0003-4819-139-9-200311040-00007 1991, Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP), JAMA, 265, 3255, 10.1001/jama.1991.03460240051027 Staessen, 1997, Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension, Lancet, 350, 757, 10.1016/S0140-6736(97)05381-6 Klag, 1996, Blood pressure and end-stage renal disease in men, N Engl J Med, 334, 13, 10.1056/NEJM199601043340103 Herrero, 2006, Renal function and cardiovascular risk in patients with essential hypertension. The “FRESHA” study, Nefrología, 26, 330 Kannel, 2000, Risk stratification in hypertension: new insights from the Framingham Study, Am J Hypertens, 131, S3, 10.1016/S0895-7061(99)00252-6 Galán, 2005, Clustering of behavior-related risk factors and its association with subjective health, Gac Sanit, 19, 370, 10.1157/13080135 Kannel, 1986, Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial, Am Heart J, 112, 825, 10.1016/0002-8703(86)90481-3 World Health Organization. Obesity: Preventing and managing the global epidemic. Ginebra: WHO Technical Report Series no. 894; 2000. Grundy, 2005, American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, Circulation, 112, 2735, 10.1161/CIRCULATIONAHA.105.169404 Álvarez-Sala, 2005, Estudio Prevencat: control del riesgo cardiovascular en Atención Primaria, Med Clin (Barc), 124, 406, 10.1157/13072841 Álvarez Cosmea, 2005, Diferencias en la prevalencia del síndrome metabólico según las definiciones del ATP III y la OMS, Med Clin (Barc), 124, 368, 10.1157/13072570 Álvarez-León, 2003, Prevalence of the metabolic syndrome in the population of Canary Islands, Spain, Med Clin (Barc), 120, 172 García-Puig, 2006, Glucose metabolism in patients with essential hypertension, Am J Med, 119, 318, 10.1016/j.amjmed.2005.09.010 De la Sierra, 2006, Prevalence and general features of the metabolic syndrome in the Spanish hypertensive population, Med Clin (Barc), 126, 406, 10.1157/13086123 Suárez, 2006, Sould we perform an echocardiogram in hypertensive patients classified as having low and medium risk?, Int J Cardiol, 106, 41, 10.1016/j.ijcard.2004.12.076 Conroy, 2003, Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project, Eur Heart J, 24, 987, 10.1016/S0195-668X(03)00114-3 De Backer, 2003, Executive summary. European guidelines on cardiovascular disease prevention in clinical practice, Eur Heart J, 24, 1601, 10.1016/S0195-668X(03)00347-6 Khosla, 2006, Expanding the definition of hypertension to incorporate global cardiovascular risk, Current Hypertens Rep, 8, 384, 10.1007/s11906-006-0082-z Leal, 2006, Information on cardiovascular risk in hypertense patients monitored in primary care. Does it improve our efficacy?, Aten Primaria, 38, 102 Hall, 2003, Controlled trial of effect of documented cardiovascular risk scores on prescribing, BMJ, 326, 251, 10.1136/bmj.326.7383.251 Banegas, 2004, Number needed to treat to gain one controlled hypertensive, Curr Hypertens Rep, 6, 75, 10.1007/s11906-004-0077-6 Banegas, 2004, Blood pressure control and physician management of hypertension in hospital hypertension units in Spain, Hypertension, 43, 1338, 10.1161/01.HYP.0000127424.59774.84 Barrios V, Escobar C, Calderón A, Llisterri JL, Echarri R, Alegría E, et al. Blood pressure and lipid goal attainment in the hypertensive population assisted in primary care setting in Spain. J Clin Hypertens. 2007 (en prensa). Banegas, 2006, Dyslipidemia in outpatients’ clinics: the gap between control perceived by physicians and objective control patterns, Atherosclerosis, 180, 420, 10.1016/j.atherosclerosis.2005.11.011 Rodríguez-Roca, 2006, Grado de control de dislipemia en los pacientes asistidos en atención primaria. Estudio LIPICAP, Clin Invest Arterioscl, 18, 226 De la Peña, 2005, Control integral de los factores de riesgo en pacientes en alto y muy alto riesgo cardiovascular en España. Estudio CIFARC, Med Clin (Barc), 124, 44, 10.1157/13070450 Banegas, 2007, Effectiveness of blood pressure control outside the medical setting, Hypertension, 49, 62, 10.1161/01.HYP.0000250557.63490.55